Assessment of Quality of Life following Allogeneic Stem Cell Transplant for Myelofibrosis

Patient-reported outcomes (PROs) for patients with myelofibrosis (MF) have been well characterized, but little is known about quality of life (QoL) following allogeneic stem cell transplantation (allo-SCT). Medical data and PRO measures were collected before transplant and at day 30, day 100, and 1...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Autores principales: Palmer, Jeanne, Kosiorek, Heidi E., Wolschke, Christine, Fauble, Veena D.S., Butterfield, Richard, Geyer, Holly, Scherber, Robyn M., Dueck, Amylou C., Gathany, Allison, Mesa, Ruben A., Kroger, Nicolaus
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8114229/
https://ncbi.nlm.nih.gov/pubmed/31288096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.07.001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares